The significance of aryl acylamidase activity of acetylcholinesterase in osteoblast differentiation and mineralization
Osteoblast differentiation is an essential event in the developmental process, which is favoured by the production of extra cellular matrix proteins and various enzymes including discrete ones like acetylcholinesterase (AChE). Despite the fact that AChE facilitates osteoblast differentiation, the significance of its catalytic functions [esterase and aryl acylamidase (AAA) activities] in the process is yet to be ascertained. In this context, SaOS-2 cell line was used in the present study to implicate the catalytic activities of AChE in process of osteoblast differentiation and mineralization. During differentiation, it was found that the activity of both esterase and AAA increased 1.13 and 1.46 folds respectively, signifying the involvement of catalytic activities of AChE in the process. Inhibition of both the catalytic activities of AChE with edrophonium significantly reduced the amount of mineralization by decreasing the alkaline phosphatase (ALP) activity and expression of differentiation-related genes such as RUNX-2, COL1A, ALP, OC, and OP significantly (p < 0.05). Inhibition of esterase activity without altering the AAA activity using gallamine significantly increased the level ALP activity and expression of differentiation-associated genes (p < 0.05), thus favouring mineralization. Therefore, this study concludes and confirms that the AAA activity of AChE is actively involved in the process of osteoblast differentiation and mineralization.
KeywordsOsteoblast Aryl acylamidase Esterase Acetylcholinesterase Differentiation Mineralization
We thank Dr. Paul G. Layer for encouragements, valuable comments, helpful discussions and counsel of the manuscript. PS acknowledges the research fellowship (DST-INSPIRE) provided by the Department of Science and Technology, Government of India.
Compliance with ethical standards
Conflict of interest
The authors of the manuscript declare no conflict of interest.
- 11.Grisaru D, Lev-Lehman E, Shapira M, Chaikin E, Lessing JB, Eldor A, Eckstein F, Soreq H (1999) Human osteogenesis involves differentiation-dependent increases in the morphogenically active 3′ alternative splicing variant of acetylcholinesterase. Mol Cell Biol 19(1):788–795CrossRefPubMedPubMedCentralGoogle Scholar
- 13.Akincioglu A, Akincioglu H, Gulcin I, Durdagi S, Supuran CT, Goksu S (2015) Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: novel sulfamoylcarbamates and sulfamides derived from acetophenones. Bioorg Med Chem 23(13):3592–3602. doi: 10.1016/j.bmc.2015.04.019 CrossRefPubMedGoogle Scholar
- 25.Yadav MC, Simao AM, Narisawa S, Huesa C, McKee MD, Farquharson C, Millan JL (2011) Loss of skeletal mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function: a unified model of the mechanisms of initiation of skeletal calcification. J Bone Miner Res 26(2):286–297. doi: 10.1002/jbmr.195 CrossRefPubMedGoogle Scholar
- 28.Fujita T, Azuma Y, Fukuyama R, Hattori Y, Yoshida C, Koida M, Ogita K, Komori T (2004) Runx2 induces osteoblast and chondrocyte differentiation and enhances their migration by coupling with PI3K-Akt signaling. J Cell Biol 166(1):85–95. doi: 10.1083/jcb.200401138 CrossRefPubMedPubMedCentralGoogle Scholar
- 36.Bouleftour W, Bouet G, Granito RN, Thomas M, Linossier MT, Vanden-Bossche A, Aubin JE, Lafage-Proust MH, Vico L, Malaval L (2015) Blocking the expression of both bone sialoprotein (BSP) and osteopontin (OPN) impairs the anabolic action of PTH in mouse calvaria bone. J Cell Physiol 230(3):568–577. doi: 10.1002/jcp.24772 CrossRefPubMedGoogle Scholar
- 39.Wu M, Hesse E, Morvan F, Zhang JP, Correa D, Rowe GC, Kiviranta R, Neff L, Philbrick WM, Horne WC, Baron R (2009) Zfp521 antagonizes Runx2, delays osteoblast differentiation in vitro, and promotes bone formation in vivo. Bone 44(4):528–536. doi: 10.1016/j.bone.2008.11.011 CrossRefPubMedGoogle Scholar